Back to top

messenger-rna: Archive

Zacks Equity Research

Moderna (MRNA) Up on FDA Filing for Second COVID Booster Jab

Moderna (MRNA) seeks the FDA's authorization for a fourth dose of its COVID vaccine in adults who already got an initial authorized booster dose of the same in the United States.

PFEPositive Net Change VRTXPositive Net Change MRNANegative Net Change BNTXNegative Net Change

Zacks Equity Research

Moderna (MRNA) Up More Than 30% in 10 Days: What Lies Ahead?

Moderna's (MRNA) shares are rising presumably in anticipation of rising demand for its COVID-19 vaccine amid authorization for younger population and the fear of another global infection wave.

PFEPositive Net Change MRKPositive Net Change MRNANegative Net Change BNTXNegative Net Change

Zacks Equity Research

Moderna (MRNA) Early-Stage HIV Vaccine Study Begins, Stock Up

Moderna (MRNA) starts dosing in an mRNA-based HIV vaccine study.

PFEPositive Net Change VRTXPositive Net Change MRNANegative Net Change BDSIPositive Net Change

Zacks Equity Research

Zimmer Biomet (ZBH) New WalkAI Model to Bolster Robotics Arm

WalkAI adds powerful predictive analytic capabilities to ZBEdge, Zimmer Biomet's (ZBH) suite of integrated digital and robotic technologies.

OMINegative Net Change ABCPositive Net Change HSICPositive Net Change ZBHPositive Net Change